Muscular dystrophy is a progressively debilitating genetic disorder with no cause-related treatment and very few supportive treatment options. However, a recent compassionate-use study using mesenchymal stem cells from the umbilical cord has shown significant improvement in several muscle groups with no severe side effects. In a study led by doctors at Klara Medical Center (KMC) , Czestochowa, Poland, mesenchymal stem cells (MSC) isolated from Wharton’s jelly, a substance present in the umbilical cord, were used successfully to treat patients with muscular dystrophy.
The findings of this compassionate-use study are published in STEM CELLS Translational Medicine. Current limitations in Muscular Dystrophy treatment Muscular dystrophies (MD) are a heterogeneous group of rare and abnormal gene mutations that lead to progressive muscle wasting and weakness. More than 30 genes are involved…
